* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Saturday, March 14, 2026
Earth-News
  • Home
  • Business
  • Entertainment

    Labrinth Calls Out the Entertainment Industry and ‘Euphoria’ in Mysterious Post

    The Try Guys Embark on an Unforgettable Journey Through the Soul of New Orleans: Jazz, Burlesque, Voodoo, and Beyond!

    Get Inspired This Weekend with Fresh Ideas for Going Green

    Seattle’s Wing Luke Museum Announces Exciting New Executive Director

    Golden Nugget Owner Eyes Major Acquisition of Caesars Entertainment

    Inspired Entertainment Unveils Exciting Q4 2025 Earnings Results

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology

    DexCom’s Next Chapter: Unlocking Exciting Growth in Glucose Monitoring Technology

    Is Keysight Technologies (KEYS) Powering the Future of the Technology Sector?

    Eight Midwestern Universities Unite to Launch Innovative Technology Hub in San Francisco

    Top Industry Experts Reveal Crucial Insights on Globant SA and Uber Technologies

    JIATF 401 Publishes Guide to Counter-Drone Technology and Privacy Protections – U.S. Department of War (.gov)

    Could This Technology Pose the Greatest Threat to American Democracy?

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment

    Labrinth Calls Out the Entertainment Industry and ‘Euphoria’ in Mysterious Post

    The Try Guys Embark on an Unforgettable Journey Through the Soul of New Orleans: Jazz, Burlesque, Voodoo, and Beyond!

    Get Inspired This Weekend with Fresh Ideas for Going Green

    Seattle’s Wing Luke Museum Announces Exciting New Executive Director

    Golden Nugget Owner Eyes Major Acquisition of Caesars Entertainment

    Inspired Entertainment Unveils Exciting Q4 2025 Earnings Results

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology

    DexCom’s Next Chapter: Unlocking Exciting Growth in Glucose Monitoring Technology

    Is Keysight Technologies (KEYS) Powering the Future of the Technology Sector?

    Eight Midwestern Universities Unite to Launch Innovative Technology Hub in San Francisco

    Top Industry Experts Reveal Crucial Insights on Globant SA and Uber Technologies

    JIATF 401 Publishes Guide to Counter-Drone Technology and Privacy Protections – U.S. Department of War (.gov)

    Could This Technology Pose the Greatest Threat to American Democracy?

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Why DMARDs Take Time to Work for RA

January 24, 2024
in Health
Why DMARDs Take Time to Work for RA
Share on FacebookShare on Twitter

How long do you need to take a disease-modifying antirheumatic drug (DMARD) for rheumatoid arthritis before it’s fully effective? It depends on which one you use. But they all take a while, says Eric M. Ruderman, MD, a rheumatologist at Northwestern Medicine Rheumatology in Chicago. In fact, he says, DMARDs used to be called SARDs, slow-acting antirheumatic drugs.

When you take DMARDs, it usually takes 6-12 weeks to see a response, according to Ruderman. Why so long? Well, to explain that, it helps to understand what DMARDs do.

How Do DMARDs Work for RA?

Once, nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen were the main treatment for rheumatoid arthritis (RA). They treat joint pain and inflammation. They do not prevent joint damage. If these didn’t do the trick, your rheumatologist might consider giving you a DMARD, which was a newer type of medication.

That’s changed in the last 15-20 years, says Ruderman. Now, DMARDs are prescribed as soon as you’re diagnosed with RA. Why? “We recognize that just treating symptoms really doesn’t cover it. You have to treat the underlying disease. That’s what gives you the best long-term outcomes,” he says.

Each type of DMARD works differently. But they all go beyond treating symptoms to block inflammation and slow the disease process. This minimizes the joint damage and complications that inflammation from RA can cause, such as heart problems, says Ruderman.

“People really belong on a disease-modifying drug right out of the gate because our goal these days is not just to manage the symptoms, but to put people in remission if we can. And we can most of the time,” Ruderman says.

NSAIDs and corticosteroids are an important part of an RA treatment plan, too, but they only improve symptoms caused by inflammation. DMARDs are the foundation because they work with your immune system to slow down or even stop the disease

.

Why Do DMARDs Take So Long to Work?

Because a DMARD medication treats underlying inflammation, “it’s not going to work overnight,” Ruderman says.” People often see some benefit right away, but it usually takes longer to ease symptoms like swollen, painful joints and morning stiffness, he says.

“The other complicating factor is that, particularly for methotrexate, there are dose issues,”  Ruderman says.

Your rheumatologist will probably start you on a low dose for about a month. If that doesn’t help enough, your doctor may bump up the amount. It usually takes about 3 months to get to a point where you and your doctor can decide whether the medicine is working. With some kinds of DMARDs, it takes up to 6 months for the maximum benefit, he says.

What Are the Different Types of DMARDs?

Your doctor can choose from among conventional DMARDS, which fight inflammation by working on your immune system as a whole, and biologic DMARDs, which target certain proteins involved in the immune response.   

DMARD drugs used for RA include:

AzathioprineHydroxychloroquineLeflunomide (Arava)Methotrexate (Rheumatrex, Trexall)SulfasalazineBiologic DMARDs known as tumor necrosis factor inhibitors, such as adalimumab (Humira), certolizumab (Cimzia), etanercept (Enbrel), golimumab (Simponi), and infliximab (Avsola, Inflectra, Remicade, Renflexis,)Biologics called B-cell inhibitors, including rituximab (Rituxan, Ruxience, Truxima)Biologics called selective costimulation modulators, such as abatacept (Orencia)Janus kinase inhibitors, such as baricitinib (Olumiant), tofacitinib (Xeljanz), and upadacitinib (Rinvoq)

Methotrexate is usually the first DMARD doctors prescribe for people with RA. Hydroxychloroquine, leflunomide, and sulfasalazine are also common treatments.

Ruderman says leflunomide and methotrexate usually take the longest to reach full effectiveness.

Biologic DMARD drugs are quicker. “We often expect to see some meaningful benefit by about 6 weeks, sometimes sooner,” says Ruderman.

The newer kinase inhibitors, which include tofacitinib and upadacitinib, work fastest, he says. “I typically expect to see a benefit within about a month,” he says.

What Does Successful Treatment Look Like?

The ideal outcome is that you end up in remission.

“That’s our goal, especially if we treat people early,” Ruderman says. “It’s hard to know exactly, but somewhere between 60% and 75% of the time, we can actually get people into remission.” This may take several tries with different medications.

Ruderman defines remission as no swollen, painful, or tender joints. You might have a day every week or two where you don’t feel great or are achy in the morning, but this improves quickly. “For the most part, you just don’t feel like the disease is an issue in your life,” he says.

Unfortunately, if you’ve had RA for years, you probably already have a lot of damage, Ruderman says. That’s because the older treatments weren’t as effective. DMARDs can’t undo past damage from RA. But they can slow down the disease and may prevent further harm to your joints.

How Do You Know Which Drug Is Best for You?

While RA treatments have come a long way, there’s no way to predict which medication will work best for you. You may have to try three or four medicines to find one that gets results.

“It’s great that we have so many good drugs, and they all work really well,” says Ruderman. “We just don’t have a good way to choose between them.”

How Long Do You Need to Take DMARDs?

“The answer is pretty much forever,” Ruderman says. “RA is a lifelong disease and none of the medicines we have cure it. They control it.”

Once you find something that works, you should be able to use it for up to 15-20 years before you need to try something else. So far, research has shown that stopping your medicine altogether, even when you’re in remission, causes symptom flare-ups.

“It’s just not worth it,” says Ruderman. But your rheumatologist may be able to taper your dose a bit or let you go longer between doses once you’re in remission.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : WebMD – https://www.webmd.com/rheumatoid-arthritis/features/dmards-take-time?src=RSS_PUBLIC

Tags: DMARDshealth
Previous Post

Living With MS: Tips for Young Women

Next Post

Stop Using the Medicine Cabinet. Oh, and Now Clean It Out

Exploring the Fascinating Diversity, Ecology, Cell Biology, and Evolution of Asgard Archaea

March 14, 2026

O-Zone: Evangel 79, Science and Arts 74 – KY3

March 14, 2026

How Course-Based Research Experiences Are Unlocking Exciting New Frontiers in Science

March 14, 2026

New Owner Cuts Majority of Staff at Three Salt Lake Magazines

March 14, 2026

Kiké Seizes the Moment to Shine for Puerto Rico on the World Stage

March 14, 2026

Iran Threatens to Cripple Global Economy as Trump Declares Regime’s Imminent Collapse

March 14, 2026

Labrinth Calls Out the Entertainment Industry and ‘Euphoria’ in Mysterious Post

March 14, 2026

Fourth Purdue AMR Conference Promotes Collaboration to Address Global Health Threat of Antimicrobial Resistance through PVM’s One Health Initiative. – Purdue University College of Veterinary Medicine

March 14, 2026

The Rundown | Last Week in Michigan Politics (3-13-26) – WZZM13.com

March 14, 2026

DexCom’s Next Chapter: Unlocking Exciting Growth in Glucose Monitoring Technology

March 14, 2026

Categories

Archives

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Feb    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (1,117)
  • Economy (1,135)
  • Entertainment (22,012)
  • General (20,397)
  • Health (10,173)
  • Lifestyle (1,149)
  • News (22,149)
  • People (1,138)
  • Politics (1,153)
  • Science (16,351)
  • Sports (21,637)
  • Technology (16,118)
  • World (1,128)

Recent News

Exploring the Fascinating Diversity, Ecology, Cell Biology, and Evolution of Asgard Archaea

March 14, 2026

O-Zone: Evangel 79, Science and Arts 74 – KY3

March 14, 2026
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version